A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Annals of oncology
Year: 2011, Jahrgang: 22, Heft: 3, Pages: 609-17 |
| ISSN: | 0923-7534 |
| Online-Zugang: |
|
| Verfasserangaben: | Schneeweiss, A.; Marmé, F. ... Sinn, H. P. ... |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1632869284 | ||
| 003 | DE-627 | ||
| 005 | 20240705213255.0 | ||
| 007 | tu | ||
| 008 | 120529s2011 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)1632869284 | ||
| 035 | |a (DE-576)366015516 | ||
| 035 | |a (DE-599)BSZ366015516 | ||
| 035 | |a (OCoLC)1341153533 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 2 | |a A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer |c Schneeweiss, A.; Marmé, F. ... Sinn, H. P. ... |
| 264 | 1 | |c 2011 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 oth | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 oth | |
| 700 | 1 | |a Sinn, Peter |d 1957- |0 (DE-588)1022590944 |0 (DE-627)717004783 |0 (DE-576)365646342 |4 oth | |
| 773 | 0 | 8 | |i In |t Annals of oncology |d Oxford : Elsevier, 1990 |g 22(2011), 3, Seite 609-17 |w (DE-627)130852708 |w (DE-600)1025984-3 |w (DE-576)025085018 |x 0923-7534 |7 nnas |a A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer |
| 773 | 1 | 8 | |g volume:22 |g year:2011 |g number:3 |g pages:609-17 |g extent:9 |a A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Schneeweiss, Andreas, 1961 - |t A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer |d 2011 |w (DE-627)1818817322 |
| 951 | |a AR | ||
| 992 | |a 20120529 | ||
| 993 | |a Article | ||
| 998 | |g 1022590944 |a Sinn, Peter |m 1022590944:Sinn, Peter |d 910000 |d 912000 |e 910000PS1022590944 |e 912000PS1022590944 |k 0/910000/ |k 1/910000/912000/ |p 7 | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 910000 |d 910400 |e 910000PM132561972 |e 910400PM132561972 |k 0/910000/ |k 1/910000/910400/ |p 2 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1632869284 |e 3285691042 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1632869284"]},"relHost":[{"recId":"130852708","id":{"zdb":["1025984-3"],"issn":["0923-7534"],"eki":["130852708"]},"origin":[{"publisherPlace":"Oxford ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-"}],"pubHistory":["1.1990 -"],"note":["Ungezählte Beil.: Suppl"],"title":[{"subtitle":"driving innovation in oncology : an official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology","title_sort":"Annals of oncology","title":"Annals of oncology"}],"type":{"bibl":"periodical"},"disp":"A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancerAnnals of oncology","language":["eng"],"part":{"extent":"9","volume":"22","pages":"609-17","year":"2011","text":"22(2011), 3, Seite 609-17","issue":"3"},"titleAlt":[{"title":"official journal of the European Society for Medical Oncology"}]}],"recId":"1632869284","physDesc":[{"extent":"9 S."}],"language":["eng"],"name":{"displayForm":["Schneeweiss, A.; Marmé, F. ... Sinn, H. P. ..."]},"type":{"bibl":"article-journal"},"person":[{"display":"Schneeweiss, Andreas","family":"Schneeweiss","given":"Andreas","role":"oth"},{"role":"oth","given":"Frederik","display":"Marmé, Frederik","family":"Marmé"},{"role":"oth","given":"Peter","family":"Sinn","display":"Sinn, Peter"}],"title":[{"title":"A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer","title_sort":"randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer"}],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}]} | ||
| SRT | |a RANDOMIZED2011 | ||